AQR Apex UCITS Fund B3

Register to Unlock Ratings
Performance History31/03/2021
Growth of 1,000 (GBP) Advanced Graph
AQR Apex UCITS Fund B3
Fund--18.0-8.9-12.89.8
+/-Cat--14.5-9.2-17.2-
+/-B’mrk--17.7-11.2-22.4-
 
Key Stats
NAV
31/03/2021
 EUR 80.17
Day Change -1.02%
Morningstar Category™ Multistrategy EUR
ISIN LU1532680615
Fund Size (Mil)
24/05/2024
 USD 455.43
Share Class Size (Mil)
01/04/2021
 USD 1.06
Max Initial Charge -
Ongoing Charge
16/02/2024
  1.00%
Investment Objective: AQR Apex UCITS Fund B3
The investment objective of the Fund is to seek total returns commensurate with its long-term risk target. The Fund will allocate its assets to three investment sub-strategies, each sub-strategy having a distinguishable set of investment objectives and the Market Neutral Security Selection Strategy. There can be no assurance that the Fund will achieve its investment objective.
Returns
Trailing Returns (GBP)31/03/2021
YTD9.83
3 Years Annualised-9.03
5 Years Annualised-
10 Years Annualised-
12 Month Yield 0.00
Management
Manager Name
Start Date
Yao Ooi
01/02/2017
Andrea Frazzini
01/02/2017
Click here to see others
Inception Date
01/02/2017
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
Not BenchmarkedMorningstar EU Cau Gbl Tgt Alloc NR EUR
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNo
GrowthYes
IncomeNo
HedgingNo
OtherNot Specific
Portfolio Profile for  AQR Apex UCITS Fund B3-
Morningstar Style Box®
Equity Style
Morningstar Style Box®
Fixed Income Style
Asset Allocation
  % Long% Short% Net Assets
Fixed Income
Effective Maturity-
Effective Duration-
Top 5 Regions%
No Data Available
Top 5 Sectors%
No Data Available
Top 5 HoldingsSector%
No Data Available
AQR Apex UCITS Fund B3

Related

In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures